Popolazione Mix: NEONATO-BAMBINO

Filtra

Data

Early Intervention for Children Aged 0 to 2 Years With or at High Risk of Cerebral Palsy: International Clinical Practice Guideline Based on Systematic Reviews

Expanded access program with Nusinersen in SMA type I in Italy: Strengths and pitfalls of a successful experience

Onasemnogene abeparvovec in spinal muscular atrophy: predictors of efficacy and safety in na‹ve patients with spinal muscular atrophy and following switch from other therapies

Cerebral Palsy: Early Markers of Clinical Phenotype and Functional Outcome

Torna in alto